Chloroform → 3-(5-Cyano-2-nitrophenyl)-5-(3-cyanophenyl)isoxazole

HRID 553078Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 553078
Br[C:2]1[CH:3]=[CH:4][C:5]([N+:20]([O-:22])=[O:21])=[C:6]([C:8]2[CH:12]=[C:11]([C:13]3[CH:18]=[CH:17][CH:16]=[C:15](Br)[CH:14]=3)[O:10][N:9]=2)[CH:7]=1.[CH:23]([Cl:26])(Cl)Cl.Br[C:28]1[CH:29]=[CH:30][C:31]([O:46][CH3:47])=[C:32]([C:34]2[CH:38]=[C:37]([C:39]3[CH:44]=[CH:43][CH:42]=[C:41](Br)[CH:40]=3)[O:36][N:35]=2)[CH:33]=1.Br[C:49]1[CH:53]=[CH:52][O:51][N:50]=1>C(Cl)Cl>[C:49]([C:2]1[CH:3]=[CH:4][C:5]([N+:20]([O-:22])=[O:21])=[C:6]([C:8]2[CH:12]=[C:11]([C:13]3[CH:18]=[CH:17][CH:16]=[C:15]([C:34]#[N:35])[CH:14]=3)[O:10][N:9]=2)[CH:7]=1)#[N:50].[C:8]([C:28]1[CH:29]=[CH:30][C:31]([O:46][CH3:47])=[C:32]([C:34]2[CH:38]=[C:37]([C:39]3[CH:44]=[CH:43][CH:42]=[C:41]([C:49]#[N:50])[CH:40]=3)[O:36][N:35]=2)[CH:33]=1)#[N:9].[Cl:26][C:23]1[CH:28]=[CH:33][C:32]([C:34]#[N:35])=[CH:31][C:30]=1[C:49]1[CH:53]=[C:52]([C:3]2[CH:2]=[CH:7][C:6]([C:8]#[N:9])=[CH:5][CH:4]=2)[O:51][N:50]=1

Komponenten

8

Edukt 4

HCID 6212ChloroformHCID 139338913-Bromo-1,2-oxazoleHCID 166591733-(5-Bromo-2-nitrophenyl)-5-(3-bromophenyl)isoxazoleHCID 166593443-(5-Bromo-2-methoxyphenyl)-5-(3-bromophenyl)isoxazole

Produkt 3

HCID 166592173-(5-Cyano-2-nitrophenyl)-5-(3-cyanophenyl)isoxazoleHCID 166593493-(5-Cyano-2-methoxyphenyl)-5-(3-cyanophenyl)isoxazoleHCID 166594683-(2-Chloro-5-cyanophenyl)-5-(4-cyanophenyl)isoxazole

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

3-(5-Cyano-2-nitrophenyl)-5-(3-cyanophenyl)isoxazole (501) was prepared from bromoisoxazole 49j as light yellow crystals (0.18 g, 24%): mp 225-227° C. (CHCl3); 1H NMR δ 8.48 (s, 1H), 8.45 (s, 1H), 8.35 (m, 2H), 8.25 (d, J=7.7 Hz, 1H), 8.05 (d, J=7.7 Hz, 1H), 7.82 (t, J=7.7 Hz, 1H), 7.70 (s, 1H); HPLC (Method B) tR 6.67 min (100 area % at 265 nm). Anal. (C17H8N4O3) C, H, N. 3-(5-Cyano-2-methoxyphenyl)-5-(3-cyanophenyl)isoxazole (50m) was prepared from bromoisoxazole 49k as light yellow crystals (1.41 g, 43%): mp 241-243° C. (CH2Cl2); 1H NMR δ 8.49 (s, 1H), 8.26 (m, 2H), 8.00 (br s, 2H), 7.78 (br s, 1H), 7.68 (br s, 1H), 7.42 (s, 1H); HPLC (Method B) tR 7.36 min (97.8 area % at 265 nm). Anal. (C18H11N3O2) C, H, N. 3-(2-Chloro-5-cyanophenyl)-5-(4-cyanophenyl)isoxazole (53j) was prepared by the general method for nitriles 50 above from bromoisoxazole 53i (1.90 g, 5.28 mmol). The crude product was purified by column chromatography (CHCl3). Purified fractions were evaporated. The residue was suspended in ether and filtered off to give a pale yellow solid (0.44 g, 27%); mp 257-259° C.; 1H NMR δ 8.29 (d, J=2.1 Hz, 1H), 8.17 (d, J=8.4 Hz, 2H), 8.08 (m, 3H), 7.95 (d, J=8.4 Hz, 1H), 7.80 (s, 1H); HPLC (Method B) tR 7.55 min (92.3 area % at 265 nm). Anal. (C17H8ClN3O.0.2H2O) C, H, N.

Aufarbeitung

  1. customThe crude product was purified by column chromatography (CHCl3)
  2. customPurified fractions were evaporated
  3. filtrationfiltered off

Quellen und Nachweise

ORD-Eintrag
ord-9e9bfa9b36994bd8868e0e3740ff0e49
Quelldatensatz
uspto-grants-2011_05
Patentnummer
US07951827B2

Notizen zur Reaktion

Wird geladen…